Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeverfield Regulatory News (SFR)

Share Price Information for Severfield (SFR)

Share Price is delayed by 15 minutes
Get Live Data
26.80    -0.05 (-0.19%)
Bid:
26.25
Ask:
27.00
Spread: 0.75 (2.857%)
Market Cap: £79.14m
SFR Live PriceLast checked at - London Stock Exchange

Intraday Severfield Share Chart

Completion of successful refinancing

20 Dec 2021 16:31

RNS Number : 2525W
Severfield PLC
20 December 2021
 

20 December 2021

Severfield plc

('the Company' or 'the Group')

Completion of successful refinancing

 

Severfield plc, the market leading structural steel group, today announces the completion of a refinancing of its revolving credit facility ('RCF') with its current banking syndicate.

 

The new £50m RCF provides additional liquidity above the £25m RCF which it replaces and extends the term of the facility which now expires in December 2026. The RCF remains subject to three financial covenants, interest cover, net debt to EBITDA and debt service (cash flow) cover.

 

The new facility provides the Group with enhanced liquidity and long-term financing to help support its growth strategy.

 

 

For further information, please contact:

 

Severfield Alan Dunsmore 01845 577 896

Chief Executive Officer

 

Adam Semple 01845 577 896

Group Finance Director

 

Jefferies International Simon Hardy 020 7029 8000

 Will Soutar 020 7029 8000

 

Camarco Ginny Pulbrook 020 3757 4980

Tom Huddart 020 3757 4980

 

 

Notes to editors:

Severfield is the UK's market leader in the design, fabrication and construction of structural steel, with a total capacity of c.165,000 tonnes of steel per annum. The Group has six sites, c.1,500 employees and expertise in large, complex projects across a broad range of sectors. The Group also has an established presence in the expanding Indian market through its joint venture partnership with JSW Steel (India's largest steel producer).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCTMBFTMTTTBPB
Date   Source Headline
2nd Jun 202612:08 pmRNSVoting Rights and Share Capital Update
31st Mar 20267:00 amRNSFull Year Trading Update
11th Mar 20267:00 amRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSDirector/PDMR Shareholding
11th Feb 20267:00 amRNSAppointment of Chief Financial Officer
29th Jan 20262:45 pmRNSStrategic Review of the Modular Solutions Business
2nd Dec 20257:00 amRNSInterim Results
1st Dec 20253:54 pmRNSTotal Voting Rights
31st Oct 202510:33 amRNSDirector/PDMR Shareholding
27th Oct 20257:00 amRNSNotification of CEO Start Date & Notice of Results
3rd Oct 202510:16 amRNSHolding(s) in Company
23rd Sep 202511:11 amRNSAppointment of Interim Chief Financial Officer
11th Sep 20257:00 amRNSDirectorate Change
2nd Sep 20251:40 pmRNSResult of AGM
2nd Sep 20257:00 amRNSAGM trading update
13th Aug 20257:00 amRNSAppointment of Chief Executive Officer
29th Jul 20254:01 pmRNSDirector/PDMR Shareholding
29th Jul 202511:30 amRNSDirector/PDMR Shareholding
24th Jul 20257:43 amRNS-RProgressive publishes new research
24th Jul 20257:00 amRNSFinal Results
22nd Jul 20253:27 pmRNSHolding(s) in Company
18th Jul 20251:23 pmRNSJSW Severfield Structures Limited Option Agreement
7th Jul 20257:00 amRNSNotice of Results
4th Jun 20254:52 pmRNSTotal Voting Rights
22nd May 20257:00 amRNSHolding(s) in Company
25th Apr 20252:36 pmRNSDirector/PDMR Shareholding
24th Apr 20257:45 amRNS-RProgressive publishes new research
24th Apr 20257:00 amRNSPre-close trading update
1st Apr 20252:50 pmRNSBlock listing six monthly return
1st Apr 20252:06 pmRNSTotal Voting Rights
28th Mar 20258:15 amRNS-RProgressive publishes new research
26th Mar 20257:00 amRNSDirectorate Change
24th Mar 20259:36 amRNSChange in Director's Details Notification
3rd Mar 20257:01 amRNSShare Buyback Programme Cancellation
3rd Mar 20257:00 amRNSTrading Update
30th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
15th Jan 20258:30 amRNSTransaction in Own Shares
14th Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20243:40 pmRNSHolding(s) in Company
17th Dec 20247:00 amRNSTransaction in Own Shares
16th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20245:20 pmRNSHolding(s) in Company
10th Dec 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.